Early cystic fibrosis lung disease: Role of airway surface dehydration and lessons from preventive rehydration therapies in mice

International Journal of Biochemistry and Cell Biology

Volumn 52, Issue , 2014, Pages 174-179

  Mall, Marcus A ^a   Graeber, Simon Y ^a   Stahl, Mirjam ^a   Zhou Suckow, Zhe ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Airway surface dehydration; Cystic fibrosis; Early lung disease; Mouse model; Preventive therapy

Indexed keywords

AMILORIDE; SODIUM CHANNEL; SODIUM CHLORIDE; SODIUM ION;

AIRWAY; AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CYSTIC FIBROSIS; DEHYDRATION; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG DISEASE; MORTALITY; MOUSE; MUCUS SECRETION; NONHUMAN; PATHOGENESIS; REHYDRATION; RESPIRATORY TRACT INFLAMMATION; SURFACE PROPERTY; ANIMAL; DISEASE MODEL; FLUID THERAPY; HUMAN; LUNG; METABOLISM; PATHOLOGY; PROCEDURES;

BACTERIA (MICROORGANISMS); MUS;

ANIMALS; CYSTIC FIBROSIS; DEHYDRATION; DISEASE MODELS, ANIMAL; FLUID THERAPY; HUMANS; LUNG; MICE;

EID: 84901610159     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.02.006     Document Type: Short Survey

References (39)

1. F.J. Accurso, R.B. Moss, R.W. Wilmott, R.D. Anbar, A.E. Schaberg, and T.A. Durham et al. Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function Am J Respir Crit Care Med 183 2011 627 634
2. P. Anagnostopoulou, B. Riederer, J. Duerr, S. Michel, A. Binia, and R. Agrawal et al. SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation J Clin Invest 122 2012 3629 3634
3. F. Becq, M.A. Mall, D.N. Sheppard, M. Conese, and O. Zegarra-Moran Pharmacological therapy for cystic fibrosis: from bench to bedside J Cyst Fibros 10 Suppl. 2 2011 S129 S145
4. Y. Belessis, B. Dixon, G. Hawkins, J. Pereira, J. Peat, and R. MacDonald et al. Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index Am J Respir Crit Care Med 185 2012 862 873
5. J.H. Chen, D.A. Stoltz, P.H. Karp, S.E. Ernst, A.A. Pezzulo, and T.O. Moninger et al. Loss of anion transport without increased sodium absorption characterizes newborn porcine cystic fibrosis airway epithelia Cell 143 2010 911 923
6. A. Di, M.E. Brown, L.V. Deriy, C. Li, F.L. Szeto, and Y. Chen et al. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity Nat Cell Biol 8 2006 933 944 (Pubitemid 44314724)
7. S.H. Donaldson, W.D. Bennett, K.L. Zeman, M.R. Knowles, R. Tarran, and R.C. Boucher Mucus clearance and lung function in cystic fibrosis with hypertonic saline N Engl J Med 354 2006 241 250 (Pubitemid 43113029)
8. M. Eichinger, D.E. Optazaite, A. Kopp-Schneider, C. Hintze, J. Biederer, and A. Niemann et al. Morphologic and functional scoring of cystic fibrosis lung disease using MRI Eur J Radiol 81 2012 1321 1329
9. M.R. Elkins, M. Robinson, B.R. Rose, C. Harbour, C.P. Moriarty, and G.B. Marks et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis N Engl J Med 354 2006 229 240 (Pubitemid 43113028)
10. S.Y. Graeber, Z. Zhou-Suckow, J. Schatterny, S. Hirtz, R.C. Boucher, and M.A. Mall Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease Am J Respir Cell Mol Biol 49 2013 410 417
11. H. Grasemann, and F. Ratjen Early lung disease in cystic fibrosis Lancet Respir Med 1 2013 148 157
12. D. Hartl, A. Gaggar, E. Bruscia, A. Hector, V. Marcos, and A. Jung et al. Innate immunity in cystic fibrosis lung disease J Cyst Fibros 11 2012 363 382
13. S. Hashimoto, K. Matsumoto, Y. Gon, T. Nakayama, I. Takeshita, and T. Horie Hyperosmolarity-induced interleukin-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase Am J Respir Crit Care Med 159 1999 634 640 (Pubitemid 29084892)
14. A.F. Hoo, L.P. Thia, T.T. Nguyen, A. Bush, J. Chudleigh, and S. Lum et al. Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening Thorax 67 2012 874 881
15. + channels carrying Liddle's syndrome mutations J Biol Chem 274 1999 13894 13899
16. B. Johannesson, S. Hirtz, J. Schatterny, C. Schultz, and M.A. Mall CFTR regulates early pathogenesis of chronic obstructive lung disease in betaENaC-overexpressing mice PLoS ONE 7 2012 e44059
17. A. Livraghi-Butrico, E.J. Kelly, E.R. Klem, H. Dang, M.C. Wolfgang, and R.C. Boucher et al. Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation Mucosal Immunol 5 2012 397 408
18. A. Livraghi-Butrico, E.J. Kelly, K.J. Wilkinson, T.D. Rogers, R.C. Gilmore, and J.R. Harkema et al. Loss of CFTR function exacerbates the phenotype of Na(+) hyperabsorption in murine airways Am J Physiol Lung Cell Mol Physiol 304 2013 L469 L480
19. M.A. Mall Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models J Aerosol Med Pulm Drug Deliv 21 2008 13 24
20. + absorption produces cystic fibrosis-like lung disease in mice Nat Med 10 2004 487 493 (Pubitemid 38667907)
21. + channel-overexpressing mice Am J Respir Crit Care Med 177 2008 730 742 (Pubitemid 351490560)
22. M.A. Mall, B. Button, B. Johannesson, Z. Zhou, A. Livraghi, and R.A. Caldwell et al. Airway surface liquid volume regulation determines different airway phenotypes in liddle compared with betaENaC-overexpressing mice J Biol Chem 285 2010 26945 26955
23. R.G. Painter, V.G. Valentine, N.A. Lanson Jr., K. Leidal, Q. Zhang, and G. Lombard et al. CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis Biochemistry 45 2006 10260 10269 (Pubitemid 44384801)
24. A.A. Pezzulo, X.X. Tang, M.J. Hoegger, M.H. Alaiwa, S. Ramachandran, and T.O. Moninger et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung Nature 487 2012 109 113
25. G.B. Pier, M. Grout, and T.S. Zaidi Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung Proc Natl Acad Sci U S A 94 1997 12088 12093 (Pubitemid 27467847)
26. G. Pons, M.C. Marchand, P. d'Athis, E. Sauvage, C. Foucard, and P. Chaumet-Riffaud et al. French multicenter randomized double-blind placebo-controlled trial on nebulized amiloride in cystic fibrosis patients. The Amiloride-AFLM Collaborative Study Group Pediatr Pulmonol 30 2000 25 31 (Pubitemid 30413945)
27. E.P. Reeves, M. Williamson, S.J. O'Neill, P. Greally, and N.G. McElvaney Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis Am J Respir Crit Care Med 183 2011 1517 1523
28. M. Rosenfeld, F. Ratjen, L. Brumback, S. Daniel, R. Rowbotham, and S. McNamara et al. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial JAMA 307 2012 2269 2277
29. P.D. Sly, S. Brennan, C. Gangell, N. de Klerk, C. Murray, and L. Mott et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening Am J Respir Crit Care Med 180 2009 146 152
30. P.D. Sly, C.L. Gangell, L. Chen, R.S. Ware, S. Ranganathan, and L.S. Mott et al. Risk factors for bronchiectasis in children with cystic fibrosis N Engl J Med 368 2013 1963 1970
31. K.W. Southern, P.G. Noone, D.G. Bosworth, V.A. Legrys, M.R. Knowles, and P.M. Barker A modified technique for measurement of nasal transepithelial potential difference in infants J Pediatr 139 2001 353 358 (Pubitemid 32889510)
32. M. Stahl, C. Joachim, K. Blessing, S. Hammerling, O. Sommerburg, and P. Latzin et al. Multiple breath washout is feasible in the clinical setting and detects abnormal lung function in infants and young children with cystic fibrosis Respiration 2014 10.1159/000357075 PMID: 24434651
33. D.A. Stoltz, D.K. Meyerholz, A.A. Pezzulo, S. Ramachandran, M.P. Rogan, and G.J. Davis et al. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth Sci Transl Med 2 2010 29ra31
34. P. Subbarao, S. Stanojevic, M. Brown, R. Jensen, M. Rosenfeld, and S. Davis et al. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline Am J Respir Crit Care Med 188 2013 456 460
35. X. Sun, A.K. Olivier, B. Liang, Y. Yi, H. Sui, and T.I. Evans et al. Lung phenotype of juvenile and adult CFTR-knockout ferrets Am J Respir Cell Mol Biol 2013
36. M.O. Wielpütz, M. Eichinger, Z. Zhou, K. Leotta, S. Hirtz, and S.H. Bartling et al. In vivo monitoring of cystic fibrosis-like lung disease in mice by volumetric computed tomography Eur Respir J 38 2011 1060 1070
37. Z. Zhou, D. Treis, S.C. Schubert, M. Harm, J. Schatterny, and S. Hirtz et al. Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in βENaC-overexpressing mice Am J Respir Crit Care Med 178 2008 1245 1256
38. Z. Zhou, J. Duerr, B. Johannesson, S.C. Schubert, D. Treis, and M. Harm et al. The βENaC-overexpressing mouse as a model of cystic fibrosis lung disease J Cyst Fibros 10 Suppl. 2 2011 S172 S182
39. W.W. Zuelzer, and W.A. Newton The pathogenesis of fibrocystic disease of the pancreas; a study of 36 cases with special reference to the pulmonary lesions Pediatrics 4 1949 53 69